Search All UT System Experts

Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial

Lawrence Blonde, Timothy S. Bailey, Jason Chao, Terry A. Dex, Juan Pablo Frias, Luigi F. Meneghini, Michelle Roberts, Vanita R. Aroda

Research output: Contribution to journal › Article › peer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical Characteristics and Glycemic Outcomes of Patients with Type 2 Diabetes Requiring Maximum Dose Insulin Glargine/Lixisenatide Fixed-Ratio Combination or Insulin Glargine in the LixiLan-L Trial'. Together they form a unique fingerprint.

Medicine & Life Sciences